Acquirement

Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program

Eli Lilly and Company

M&A

Olon Continues its Growth Path and Announces a New Acquistion

Olon

Cell Therapy

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

Genezen

Vantage Nutrition LLC Acquires ComboCap Inc

Vantage Solutions

M&A

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement

Pluristyx

Integration

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

Actylis

Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

AcuraBio

Audit Service Merger

Merger of Rephine with Forum Auditorias & TDV Creates Clear Market Leader in Global GMP Audit Services

Rephine

M&A

ProductLife Group Strengthens Foothold in Northern Europe with Pharma IT Acquisition

ProductLife Group

M&A

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Novo Holdings A/S

M&A

Incannex to Acquire APIRx Pharmaceuticals USA, LLC

Incannex Healthcare Limited

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

Ginkgo Bioworks

CDMO Acquisition

Vibalogics Acquired by Top Global CDMO Recipharm AB

Vibalogics

CDMO Acquisition

Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.

Recipharm AB